The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency

[1]  K. Ohashi,et al.  Roles of the cytoskeleton, cell adhesion and rho signalling in mechanosensing and mechanotransduction. , 2017, Journal of biochemistry.

[2]  R. Fässler,et al.  Integrin-mediated mechanotransduction , 2016, The Journal of cell biology.

[3]  Pieter Vader,et al.  Extracellular vesicles for drug delivery. , 2016, Advanced drug delivery reviews.

[4]  Hongwei Gong,et al.  Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles , 2016, Cell Research.

[5]  Kam W. Leong,et al.  Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines , 2016 .

[6]  H. Harashima,et al.  Heterogeneity of tumor endothelial cells and drug delivery. , 2016, Advanced Drug Delivery Reviews.

[7]  Jun Wang,et al.  Promoting tumor penetration of nanoparticles for cancer stem cell therapy by TGF-β signaling pathway inhibition. , 2016, Biomaterials.

[8]  Junjian Z. Chen,et al.  Efficient extravasation of tumor-repopulating cells depends on cell deformability , 2016, Scientific Reports.

[9]  E. Erkan,et al.  Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment. , 2015, Current cancer drug targets.

[10]  T. Ochiya,et al.  A novel platform for cancer therapy using extracellular vesicles. , 2015, Advanced drug delivery reviews.

[11]  Jaehong Key,et al.  Soft Discoidal Polymeric Nanoconstructs Resist Macrophage Uptake and Enhance Vascular Targeting in Tumors. , 2015, ACS nano.

[12]  Jianbin Tang,et al.  The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment. , 2015, ACS nano.

[13]  F. Caruso,et al.  The role of capsule stiffness on cellular processing , 2015, Chemical science.

[14]  S. Mitragotri,et al.  Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. , 2015, ACS nano.

[15]  Raimo Hartmann,et al.  Stiffness-dependent in vitro uptake and lysosomal acidification of colloidal particles. , 2015, Angewandte Chemie.

[16]  Xin Wang,et al.  Epirubicin-Adsorbed Nanodiamonds Kill Chemoresistant Hepatic Cancer Stem Cells , 2014, ACS nano.

[17]  P. Choyke,et al.  Cancer Drug Delivery: Considerations in the Rational Design of Nanosized Bioconjugates , 2014, Bioconjugate chemistry.

[18]  Andrew L. Ferguson,et al.  Investigating the optimal size of anticancer nanomedicine , 2014, Proceedings of the National Academy of Sciences.

[19]  Yong Li,et al.  Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression , 2014, Nature Communications.

[20]  Lianqing Liu,et al.  Nanoscale imaging and mechanical analysis of Fc receptor-mediated macrophage phagocytosis against cancer cells. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[21]  Jing Liu,et al.  Soft fibrin gels promote selection and growth of tumourigenic cells , 2012, Nature Materials.

[22]  Guimei Zhang,et al.  Delivery of chemotherapeutic drugs in tumour cell-derived microparticles , 2012, Nature Communications.

[23]  M. Uesaka,et al.  Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. , 2011, Nature nanotechnology.

[24]  Siqing Shan,et al.  In vivo optical molecular imaging and analysis in mice using dorsal window chamber models applied to hypoxia, vasculature and fluorescent reporters , 2011, Nature Protocols.

[25]  Stephen S. Gisselbrecht,et al.  Deficiency of the cytoskeletal protein SPECC1L leads to oblique facial clefting. , 2011, American journal of human genetics.

[26]  Anikó Szalai,et al.  Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. , 2011, Blood.

[27]  M. Thanou,et al.  Targeting nanoparticles to cancer. , 2010, Pharmacological research.

[28]  Michael Höpfner,et al.  The shunt problem: control of functional shunting in normal and tumour vasculature , 2010, Nature Reviews Cancer.

[29]  B. Leyland-Jones,et al.  Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling , 2010, British Journal of Cancer.

[30]  Zhuoshun Yang,et al.  Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration , 2009, PloS one.

[31]  David J. Mooney,et al.  Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.

[32]  Hui Wang,et al.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.

[33]  S. Werner,et al.  Active Caspase-1 Is a Regulator of Unconventional Protein Secretion , 2008, Cell.

[34]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[35]  Stephen Lam,et al.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. , 2007, Cancer research.

[36]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[37]  E. Fredlund,et al.  Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. , 2005, Seminars in cell & developmental biology.

[38]  H. Saragovi,et al.  Novel approaches for targeted cancer therapy. , 2004, Current cancer drug targets.

[39]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[40]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[41]  S. Brenner,et al.  Inhibition of actin polymerization by latrunculin A , 1987, FEBS letters.

[42]  Samir Mitragotri,et al.  Impact of particle elasticity on particle‐based drug delivery systems☆ , 2017, Advanced drug delivery reviews.

[43]  A. Sica,et al.  Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages. , 2017, Journal of hepatology.

[44]  Mengjiao Zhou,et al.  Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[45]  Xiongbin Lu,et al.  Nanoparticle systems reduce systemic toxicity in cancer treatment. , 2016, Nanomedicine.

[46]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[47]  A. Holzinger.  Jasplakinolide: an actin-specific reagent that promotes actin polymerization. , 2009, Methods in molecular biology.